Synthetic Biologics Reports 2020 First Quarter Operational Highlights and Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. USO
3. SPY
4. NVDA
5. OPCH
6. BBIO
7. GOOGL
8. AMD
9. CHRW
10. SKYD

Go back to Synthetic Biologics Reports 2020 First Quarter Operational Highlights and Financial Results

Synthetic Biologics (SYN) Tops Q1 EPS by 7c

May 5, 2020 4:37 PM EDT

Synthetic Biologics (NYSE: SYN) reported Q1 EPS of ($0.20), $0.07 better than the analyst estimate of ($0.27).

"During the first quarter of 2020, we remained sharply focused on executing our strategy to advance our portfolio of GI and microbiome-focused clinical development programs while responding to the unprecedented global health and economic crisis sparked by the COVID-19 pandemic," said Steven A. Shallcross, Chief Executive and Financial Officer of Synthetic Biologics. "Recommendations by local governments, hospitals and healthcare organizations to concentrate resources... More